I riconoscimenti normativi per Wegovy in Messico e Brasile ampliano l'idoneit a milioni di adulti con BMI elevato, mentre i dati sugli esiti cardiovascolari supportano l'uso nella prevenzione secondaria

Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone

Designed to rehydrate, replenish, and revive, this powerful drip includes Zofran to curb nausea, plus a blend of essential vitamins and minerals to restore your energy and banish brain fog
Refrain from engaging in a sedentary lifestyle while you are on semaglutide
Obesity pharmacotherapy reduces food intake and enhances satiety without the need to alter meal timing (62, 63), thus avoiding the potential health risks and reward-based eating behaviors reportedly associated with IF (44, 45)
Either pathway damages the peptide structure